Cure My Disease

Don't miss your cure!

 Log in / Sign up

Instagram and WhatsApp used to teach women about cancer screenings

NCT ID NCT06939699

Knowledge-focused Sponsor: Emine Ergin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study looks at whether daily social media posts can improve women's knowledge and attitudes about breast, cervical, and colorectal cancer screenings. About 132 women in Turkey who have never been screened will receive either daily educational content on WhatsApp or Instagram for 8 weeks, or two standard online sessions. The goal is to see if social media can be an effective tool to increase screening awareness and digital health literacy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

132 people

The number who actually took part.

Started

Jun 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 70 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female * Aged 30-70 years * Applied to Medipol Mega University Hospital in Istanbul between June and August 2025 * Had not previously undergone breast, cervical, or colorectal cancer screening * Actively used both WhatsApp and Instagram * Had access to a digital device and internet connection that enabled participation in the educational program * Voluntarily agreed to participate and provided written informed consent Exclusion Criteria: * Previous diagnosis of any type of cancer * Previous participation in any breast, cervical, or colorectal cancer screening procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer screening are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer screening Cervical cancer screening Colorectal cancer screening Digital health literacy

Contacts and locations

Locations

  • Medipol Mega University Hospital

    Istanbul, 34214, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.